These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 31006593)
21. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany. März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254 [TBL] [Abstract][Full Text] [Related]
22. Baseline serum sitosterol level as predictor of adverse clinical events in acute coronary syndrome patients with dyslipidaemia: A sub-analysis of HIJ-PROPER. Yamaguchi J; Kawada-Watanabe E; Koyanagi R; Arashi H; Sekiguchi H; Nakao K; Tobaru T; Tanaka H; Oka T; Endo Y; Saito K; Uchida T; Matsui K; Ogawa H; Hagiwara N Atherosclerosis; 2018 Jul; 274():139-145. PubMed ID: 29772482 [TBL] [Abstract][Full Text] [Related]
23. Do acute coronary events affect lipid management and cholesterol goal attainment in Germany? : Results from the Dyslipidemia International study II. Gitt AK; Rieber J; Hambrecht R; Brachmann J; Graf K; Horack M; Karmann B; Vyas A; Lautsch D; Ambegaonkar B; Brudi P Wien Klin Wochenschr; 2018 Dec; 130(23-24):707-715. PubMed ID: 30178071 [TBL] [Abstract][Full Text] [Related]
24. Patients with Acute Coronary Syndrome are at High Risk Prior to the Event and Lipid Management is Underachieved Pre- and Post- Hospitalization. Vlachopoulos C; Andrikopoulos G; Terentes-Printzios D; Tzeis S; Iliodromitis EK; Richter D; Mantas I; Kartalis A; Vasilikos V; Stakos D; Patsilinakos S; Lampropoulos S; Symeonidis D; Kyrpizidis C; Marinakis N; Nikas N; Lekakis J; Tousoulis D; Vardas P Curr Vasc Pharmacol; 2018; 16(4):405-413. PubMed ID: 28676022 [TBL] [Abstract][Full Text] [Related]
25. Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study. Ray KK; Aguiar C; Arca M; Connolly DL; Eriksson M; Ferrières J; Laufs U; Mostaza JM; Nanchen D; Bardet A; Lamparter M; Chhabra R; Soronen J; Rietzschel E; Strandberg T; Toplak H; Visseren FLJ; Catapano AL; Eur J Prev Cardiol; 2024 Nov; 31(15):1792-1803. PubMed ID: 38861400 [TBL] [Abstract][Full Text] [Related]
26. Lipid Management and 2-Year Clinical Outcomes in Japanese Patients with Acute Coronary Syndrome: EXPLORE-J. Nakamura M; Ako J; Arai H; Hirayama A; Nohara A; Murakami Y; Ozaki A; Harada-Shiba M J Atheroscler Thromb; 2021 Dec; 28(12):1307-1322. PubMed ID: 33612707 [TBL] [Abstract][Full Text] [Related]
27. Role of Lipid-Lowering Therapy in Low-Density Lipoprotein Cholesterol Goal Attainment: Focus on Patients With Acute Coronary Syndrome. Wang Q; Liang C J Cardiovasc Pharmacol; 2020 Dec; 76(6):658-670. PubMed ID: 33002965 [TBL] [Abstract][Full Text] [Related]
28. Prehospital statin use and low-density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project. Xing Y; Liu J; Hao Y; Liu J; Huo Y; Smith SC; Ge J; Ma C; Han Y; Fonarow GC; Taubert KA; Morgan L; Yang N; Zhou M; Zhao D; Am Heart J; 2019 Jun; 212():120-128. PubMed ID: 30986750 [TBL] [Abstract][Full Text] [Related]
29. The effect of the intensity of lipid-lowering medications on the LDL cholesterol treatment goals of Asian patients with dyslipidaemia in primary care. Tan NC; Goh CC; Goh SC; Koh YL; Koh KH J Clin Pharm Ther; 2016 Dec; 41(6):677-683. PubMed ID: 27641514 [TBL] [Abstract][Full Text] [Related]
30. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry. Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356 [TBL] [Abstract][Full Text] [Related]
31. Trends and predictors of high-intensity statin therapy and LDL-C goal achievement among Thai patients with acute coronary syndrome. Wongsalap Y; Jedsadayanmata A J Cardiol; 2020 Mar; 75(3):275-281. PubMed ID: 31519405 [TBL] [Abstract][Full Text] [Related]
32. The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial. Zhao SP; Yu BL; Peng DQ; Huo Y Atherosclerosis; 2014 Apr; 233(2):707-712. PubMed ID: 24603217 [TBL] [Abstract][Full Text] [Related]
33. Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation. Hajahmadi Pourrafsanjani M; Khayati Shal E; Khezrpour S High Blood Press Cardiovasc Prev; 2019 Feb; 26(1):37-43. PubMed ID: 30684247 [TBL] [Abstract][Full Text] [Related]
34. Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS). Danchin N; Almahmeed W; Al-Rasadi K; Azuri J; Berrah A; Cuneo CA; Karpov Y; Kaul U; Kayıkçıoğlu M; Mitchenko O; Ruiz AJ; Aguilar Salinas CA; Santos RD; Mercier F; Blom D; Eur J Prev Cardiol; 2018 Jul; 25(10):1087-1094. PubMed ID: 29771156 [TBL] [Abstract][Full Text] [Related]
35. Treatment practices and lipid profile of patients with acute coronary syndrome: results from a tertiary care hospital. Farmakis I; Zafeiropoulos S; Kartas A; Boulmpou A; Nevras V; Papadimitriou I; Tampaki A; Vlachou A; Markidis E; Koutsakis A; Ziakas A; Karvounis H; Giannakoulas G Acta Cardiol; 2020 Oct; 75(6):527-534. PubMed ID: 31219734 [No Abstract] [Full Text] [Related]
36. Achievement of target LDL-cholesterol level in patients with acute coronary syndrome undergoing percutaneous coronary intervention: The JET-LDL registry. Ferlini M; Munafò A; Varbella F; Delnevo F; Solli M; Trabattoni D; Piccaluga E; Cardile A; Canova P; Rossini R; Celentani D; Ugo F; Taglialatela V; Airoldi F; Rognoni A; Oliva F; Porto I; Carugo S; Castiglioni B; Lettieri C; Chinaglia A; Currao A; Patti G; Oltrona Visconti L; Musumeci G Int J Cardiol; 2024 Feb; 397():131659. PubMed ID: 38101704 [TBL] [Abstract][Full Text] [Related]
37. An innovative lipid-lowering approach to enhance attainment of low-density lipoprotein cholesterol goals. Buonvino C; Chopard R; Guillon B; Puymirat E; Farnier M; Ferrières J; Krempf M; Bruckert E; Meneveau N; Schiele F Eur Heart J Acute Cardiovasc Care; 2020 Dec; 9(8):879-887. PubMed ID: 32363879 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of dyslipidaemia and the impact of hypolipidemic therapy on prognosis in high and very high risk patients through the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) Registry. Dyrbuś K; Osadnik T; Desperak P; Desperak A; Gąsior M; Banach M Pharmacol Res; 2018 Jun; 132():204-210. PubMed ID: 29258913 [TBL] [Abstract][Full Text] [Related]
39. Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care. Marquina C; Talic S; Zomer E; Vargas-Torres S; Petrova M; Wolfe R; Abushanab D; Lybrand S; Thomson D; Stratton G; Ofori-Asenso R; Liew D; Ademi Z J Clin Lipidol; 2022; 16(4):498-507. PubMed ID: 35606299 [TBL] [Abstract][Full Text] [Related]
40. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P; J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]